| Literature DB >> 32906635 |
Mahmoud Amouzadeh Tabrizi1, Josep Ferre-Borrull1, Lluis F Marsal1.
Abstract
This review paper focuses on recent progress in optical biosensors using self-ordered nanoporous anodic alumina. We present the fabrication of self-ordered nanoporous anodic alumina, surface functionalization, and optical sensor applications. We show that self-ordered nanoporous anodic alumina has good potential for use in the fabrication of antibody-based (immunosensor), aptamer-based (aptasensor), gene-based (genosensor), peptide-based, and enzyme-based optical biosensors. The fabricated optical biosensors presented high sensitivity and selectivity. In addition, we also showed that the performance of the biosensors and the self-ordered nanoporous anodic alumina can be used for assessing biomolecules, heavy ions, and gas molecules.Entities:
Keywords: aptasensor; enzyme-based biosensor; immunosensor; nanoporous anodic alumina; optical biosensor; peptide-based biosensor
Mesh:
Substances:
Year: 2020 PMID: 32906635 PMCID: PMC7570681 DOI: 10.3390/s20185068
Source DB: PubMed Journal: Sensors (Basel) ISSN: 1424-8220 Impact factor: 3.576
Figure 1Schematic representation of the interferometric reflectance spectroscopy (IRS) detection system.
Figure 2Schematic representation of the different steps to the fabrication of nanoporous anodic alumina (NAA).
Figure 3SEM images of an NAA: top views (A–D) and cross-sectional views (E,F).
Figure 4Schematic representation of the fabrication of the nanoporous anodic alumina-anti-epithelial cell adhesion molecule antibody (NAA-anti-EpCAM) for the determination of CTCs using interferometric reflectance spectroscopy (IRS).
Figure 5Schematic representation of the fabrication of the nanoporous anodic alumina-tumor necrosis factor alpha antibody (NAA-TNF) for the determination of tumor necrosis factor alpha using interferometric reflectance spectroscopy.
Figure 6Schematic representation of the fabrication of the NAA-short chain aptamer/aptamerprobe for the determination of cocaine using photoluminescence spectroscopy (PLS).
Figure 7Schematic representation of the fabrication of the NAA-aptamer/MB for the determination of Aβ oligomers using IRS.
Figure 8The mechanism of oxidation of ABTS2− by DNAzyme.
Figure 9Schematic illustration of the NAA-DNAzyme sensor for the determination of Pb2+ ions using IRS.
Figure 10Schematic representation of the genosensor for the determination of a Salmonella-specific DNA fragment using IRS.
Figure 11Schematic representation for the sensing mechanisms of cathepsin B (Cat B).
Figure 12Schematic design of the nanoporous anodic alumina-human serum albumin-thionine (NAA-HSA-TH) for the determination of cathepsin B (Cat B) using interferometric reflectance spectroscopy (IRS).
Figure 13Schematic design of the nanoporous anodic alumina-trypsin (NAA-Try) biosensor for the determination of cytochrome c (Cyt C) using IRS.
Figure 14Schematic illustration showing the fabrication of the nanoanodic alumina-Urease- fluorescein 5(6)-isothiocyanate (NAA-Urease-FLITC) biosensor for the determination of trypsin using interferometric reflectance spectroscopy (IRS).
Figure 15Schematic representation of the nanoporous optical waveguide (NPWG)-based sensing of bovine serum albumin (BSA) using nanoporous anodic alumina (NAA).
Figure 16Schematic representation for the fabrication of the interferometric reflectance spectroscopy IRS based sensor for mercury (II) Hg2+ or gold ion (III) Au3+ ion sensing.
The analytical performance of the optical biosensors and sensors by using NAA.
| Sensor | Type of Recognizers | Analyte | Method | Linear Range | LOD | Ref. |
|---|---|---|---|---|---|---|
| Nanoporous anodic alumina - Human serum albumin-Thionine | Labeled Peptide | Cathepsin B | Interferometric reflectance spectroscopy | 0.5–64.0 nM | 0.08 nM | [ |
| Nanoporous anodic alumina -Urease- Fluorescein 5(6)-isothiocyanate | Labeled Enzyme | Trypsin | Interferometric reflectance spectroscopy | 0.25–20 μg/mL | 0.06 μg/mL | [ |
| Nanoporous anodic alumina-Gelatin | Peptide | Trypsin | Interferometric reflectance spectroscopy | 1–7 mg/mL | 1 mg/mL | [ |
| Nanoporous anodic alumina-Trypsin | Enzyme (Trypsin) | Cytochrome c | Interferometric reflectance spectroscopy | 1–100 nM | 0.5 nM | [ |
| Nanoporous anodic alumina -ssDNAsal | Short chains of nucleotides (ssDNAsal) | Salmonella-specific DNA fragment | Interferometric reflectance spectroscopy | 0.25–50.0 nM | 0.01 nM | [ |
| Nanoporous anodic alumina -AptamerTB | Short chains of nucleotides (AptamerTB) | Thrombin | Interferometric reflectance spectroscopy | 0.54–2.70 nM | 7.2 nM | [ |
| Nanoporous anodic alumina -AptamerAβ | Short chains of nucleotides (AptamerAβ) | Amyloid β oligomers | Interferometric reflectance spectroscopy | 0.5–50.0 μg/mL | 0.02 μg/mL | [ |
| Nanoporous anodic alumina -Anti- Tumor necrosis factor alpha | Antibody (Anti- Tumor necrosis factor alpha) | Tumour necrosis factor-alpha | Interferometric reflectance spectroscopy | 100–1500 ng/mL | 100 ng/mL | [ |
| Nanoporous anodic alumina- Anti- Epithelial cell adhesion molecule antibody | Antibody (Anti- Epithelial cell adhesion molecule antibody) | Circulating tumor cells | Interferometric reflectance spectroscopy | 103–105 | >1000 | [ |
| Nanoporous anodic alumina-Anti- human immunoglobulin G | Antibody (Anti- human immunoglobulin G) | Human immunoglobulin G | Interferometric reflectance spectroscopy | 10–100 μg/mL | 1 μg/mL | [ |
| Nanoporous anodic alumina -Streptavidin | Peptide (Streptavidin) | Biotinylated thrombin | Interferometric reflectance spectroscopy | 10–100 μg/mL | 10 μg/mL | [ |
| Nanoporous anodic alumina gradient-index | - | Glucose | Interferometric reflectance spectroscopy | 0.025–1 M | 0.025 M | [ |
| Nanoporous anodic alumina -3-Aminopropyltriethoxysilane -Glutaraldehyde | Small molecule (Glutaraldehyde) | Vitamin C | Interferometric reflectance spectroscopy | 0.125–0.5 µM | 20 nM | [ |
| Nanoporous anodic alumina | - | Glucose | Interferometric reflectance spectroscopy | 0.0125–1 M | 0.0125 | [ |
| Nanoporous anodic alumina | - | Glucose | Interferometric reflectance spectroscopy | 0.01–1.2 M | 100 mM | [ |
| Photoluminescence spectroscopy | 0.01–1.2 M | 10 mM | ||||
| Nanoporous anodic alumina | - | L-cysteine | Interferometric reflectance spectroscopy | 0.005–0.1 M | 5 mM | [ |
| Photoluminescence spectroscopy | 0.005–0.1 M | 5 mM | ||||
| Nanoporous anodic alumina | - | Glucose | Photoluminescence spectroscopy | 0.01–1.1 mM | 0.01 mM | [ |
| Nanoporous anodic alumina -3-Mercaptopropyl-tirethoxysilane | Small molecule (3-Mercaptopropyl-tirethoxysilane) | Mercury(II) ion | Interferometric reflectance spectroscopy | 1–100 μM | 1 μM | [ |
| Nanoporous anodic alumina - Polyethylenimine- Glutaraldehyde-Polyethylenimine | Polymer | Copper (II) ion | Interferometric reflectance spectroscopy | 1–100 mg/L | 0.007 mg/L | [ |
| Nanoporous anodic alumina -3-Mercaptopropyl-tirethoxysilane | Small molecule 3-Mercaptopropyl-tirethoxysilane | Glod (III) ion | Interferometric reflectance spectroscopy | 0.1–80 µM | 0.1 µM | [ |
| Nanoporous anodic alumina -DNAzyme | Short chains of nucleotides and heme group (DNAzyme) | Lead ion (II) | Interferometric reflectance spectroscopy | 50–3200 nM | 12 nM | [ |
| Nanoporous anodic alumina-Bovine serum albumin-5- Fluorouracil | Labeled Protein (Bovine serum albumin-5- Fluorouracil) | Fluorouracil antibody | Interference localized surface plasmon resonance | 10–104 ng/mL | 10 ng/mL | [ |
| Nanoporous anodic alumina-Human serum albumin | Protein (Human serum albumin) | Quercetin | Interferometric reflectance spectroscopy | 0.25–0.5 mg/mL | 0.14 mg/mL | [ |
| Nanoporous anodic alumina- poly(acrylic acid) [poly(acrylic acid)/protonated poly(allylamine)]3 | poly(acrylic acid)/protonated poly(allylamine) | Cy5-labeled human immunoglobulin G | Photoluminescence spectroscopy | 0.02–1 ng/mL | 0.02 ng/mL | [ |
| Nanoporous anodic alumina | - | Bovine serum albumin | Nanoporous optical waveguide | 60 nM–6 µM | 5.7 pg/mm2 | [ |
| Nanoporous anodic alumina-short aptamer/Rhodamine B sequence/AptamerCocaine probe | Short chains of nucleotides (aptamerCocaine probe) | Cocaine | photoluminescence spectroscopy | 0.5–10 µM | 0.5 µM | [ |
| Nanoporous anodic alumina-short aptamer/Rhodamine B sequence/Aptamer probe | Short chains of nucleotides | Mycoplasma species | Photoluminescence spectroscopy | 20–80 copies/mL | 20 copies/mL | [ |
| Nanoporous anodic alumina-short aptamer/Rhodamine B sequence/AptamerCandida albicans species probe | Short chains of nucleotides (AptamerCandida albicans speciesprobe) | Candida albicans species | Photoluminescence spectroscopy | 7−2 × 102 CFU/mL | 8 CFU/mL | [ |
| Nanoporous anodic alumina-short aptamer/Rhodamine B sequence/Aptamer Staphylococcus aureus species genome probe | Short chains of nucleotides (Aptamer Staphylococcus aureus species) | Staphylococcus aureus species genome | Photoluminescence spectroscopy | 2–100 CFU/mL | 2 CFU/mL | [ |
| Nanoporous anodic alumina -biotin-Stripavidin/Aptamer probe | Short chains of adenines | Timine rich oligumer | Optical waveguide | 50 pM–1 nM | 20 pM | [ |